Ethics and the Future of Vascularized Composite Allotransplantation
- 28 Downloads
Purpose of Review
This paper seeks to identify and examine a number of ethical issues that persist 20 years after the field of vascularized composite allotransplantation was established. Reflection upon these issues will be essential if the field is to fulfill its promise.
A number of scholars, including the authors, have been involved in efforts to identify ethical issues in VCA. Meetings held in the US and in Europe have focused on ethical concerns related to procurement, risk-benefit, consent, and program standards, among others.
Improving the burden and risk vs. benefit ratio, strengthening the consent process, employing a patient advocate, bringing greater clarity to donation policy, and improving data sharing are identified as major ethical concerns in vascularized composite allotransplantation.
KeywordsVascularized composite allotransplantation Bioethics Consent Organ donation
Compliance with Ethical Standards
Conflict of Interest
James Benedict and Gerard Magill declare no conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 3.Bramstedt KA. A lifesaving view of vascularized composite Allotransplantation: patient experience of social death before and after face, hand, and larynx transplant. J Patient Exp. 2018;5(2):92–100 Bramstedt has advanced an argument that VCA may be regarded as “lifesaving” because the conditions treated may be seen as a form of “social death”.CrossRefGoogle Scholar
- 4.Androutsos G, Diamantis A, Vladimiros L. The first leg transplant for the treatment of a cancer by Saints Cosmas and Damian. J BUON. 2008;13920:97–304.Google Scholar
- 6.Fernandez JJG, Febres-Cordero RG, Simpson RL. The untold story of the first hand transplant: dedicated to the memory of one of the great minds of the Ecuadorian medical community and the world. J Reconstr Microsurg. 2018. https://doi.org/10.1055/s-0038-1668535.
- 11.• Shores JT, Malek V, Lee WPA, Brandacher G. Outcomes after hand and upper extremity transplantation. J Mater Sci Mater Med. 2017;28(5):72 This report of outcomes, as well as continuing and emerging challenges, provides an excellent introduction to the primary clinical and ethical concerns in the field of upper extremity transplantation. See also Molitor, note 16, for a similar account of the state of the field for VCA more generally. CrossRefGoogle Scholar
- 16.Molitor M. Transplantation of vascularized composite allografts review of current knowledge. Acta Chir Plast. 2018;58(1):19.Google Scholar
- 20.Kanitakis J, Petruzzo P, Gazarian A, Testelin S, Devauchelle B, Badet L, et al. Premalignant and malignant skin lesions in two recipients of vascularized composite tissue allografts (face, hands). Case Rep Transplant. 2015;2015:356459. https://doi.org/10.1155/2015/356459.CrossRefPubMedPubMedCentralGoogle Scholar
- 21.• Kumnig M, Jowsey-Gregoire S. Key psychosocial challenges in vascularized composite allotransplantation. World J Transplant. 2016;6(1):91 Martin Kumnig and Sheila G Jowsey-Gregoire offer critical insight into the psychosocial challenges and potential benefits in VCA. Because the ethical justification of VCA is predicated on its ability to improve the patient’s quality of life, psychosocial issues are of extreme importance. This article, after giving a brief history of VCA, addresses the challenges and potential benefits while summarizing the psychosocial research that has taken place in the field. CrossRefGoogle Scholar
- 23.Beauchamp T. Autonomy and consent. In: Miller F, Wertheimer A, editors. The ethics of consent. Oxford: Oxford University Press; 2010. p. 55–78.Google Scholar
- 25.Breidenbach, W. Conversation with Warren Breidenbach. Salzburg, Austria; 2017.Google Scholar
- 27.OPO guidance on VCA deceased donor authorization - OPTN [Internet]. Optn.transplant.hrsa.gov. 2018 [cited 31 March 2018]. Available from: https://optn.transplant.hrsa.gov/resources/guidance/opo-guidance-on-vca-deceased-donor-authorization/.
- 28.• Parent B. Informing donors about hand and face transplants: time to update the uniform anatomical gift act. J Health Biomed L. 2015;X:309–26 The paper provides an exploration of the issues raised by VCA for the organ procurement process and for potential donors. If any type of VCA is to become a routine practice, these donor and procurement concerns will have to be addressed. Google Scholar
- 32.HRSA (US). Meeting Minutes of the OPTN/UNOS Vascularized Composite Allograft (VCA) Transplantation Committee, UNOS; Apr. 7, 2017 [cited 30 Mar 2018]. Available at https://optn.transplant.hrsa.gov/media/2149/vca_meetingsummary_20170407.pdf.